Literature DB >> 28208874

Topical Corticosteroid Misuse: The Scenario in Patients Attending a Tertiary Care Hospital in New Delhi.

Santwana Mahar1, Khushbu Mahajan2, Swati Agarwal3, Hemanta Kumar Kar4, Swapan Kumar Bhattacharya5.   

Abstract

INTRODUCTION: Irrational use of Topical Corticosteroid (TC) is quite common in India due to unrestricted availability and use of TC not only by general public but also by physicians and chemists due to quick relief of symptoms in different dermatological conditions. AIM: The present study was conducted to evaluate and analyse the prevalence of misuse of TC and the causes behind misuse of TC among patients in a dermatology outpatient department in New Delhi.
MATERIALS AND METHODS: This was a cross-sectional observational questionnaire based study conducted over a period of 5 months (1st June 2015 to 30th November 2015). Patients were questioned and assessed for misuse of TCs in terms of indication, dose, frequency, duration and source of recommendation of TC.
RESULTS: During the study period, 256 (11.77%) patients presented with inappropriate use of TC out of 2174 patients attending OPD of dermatology unit of a government hospital. A total of 250 patients presented with adverse effects of TC resulting from the misuse of these drugs. There were 60%female patients and 20-29 years (38%) was the most common age group affected. We found fungal infection (38%) was the most common reason of abuse followed by facial acne (29%) and lightening of skin colour (8.4%). Friends and family (33.2%) were found to be the most influencing factors for misuse of TC. Betamethasone (72.8%) was the most commonly used TC preparation and tinea incognito (26.4%) followed by facial acne (25.6%) were the most common side effect experienced.
CONCLUSION: Outcome of the misuse of TC could be dreadful and the cause for same lies at all levels- patients, family, physicians and the regulatory authorities.

Entities:  

Keywords:  Adverse effects; Irrational use; Over the counter

Year:  2016        PMID: 28208874      PMCID: PMC5296447          DOI: 10.7860/JCDR/2016/23419.8986

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  27 in total

1.  Adolescent striae.

Authors:  N M Ammar; B Rao; R A Schwartz; C K Janniger
Journal:  Cutis       Date:  2000-02

2.  [Prevalence of the use of skin bleaching cosmetics in two areas in Dakar (Sénégal)].

Authors:  I Wone; A Tal-Dia; O F Diallo; M Badiane; K Touré; I Diallo
Journal:  Dakar Med       Date:  2000

3.  Misuse of topical corticosteroids: a clinical study in an Iraqi hospital.

Authors:  M A Al-Dhalimi; N Aljawahiry
Journal:  East Mediterr Health J       Date:  2006-11       Impact factor: 1.628

4.  Eyelid dermatitis to red face syndrome to cure: clinical experience in 100 cases.

Authors:  M J Rapaport; V Rapaport
Journal:  J Am Acad Dermatol       Date:  1999-09       Impact factor: 11.527

Review 5.  Corticosteroids.

Authors:  J Hughes; M Rustin
Journal:  Clin Dermatol       Date:  1997 Sep-Oct       Impact factor: 3.541

6.  The pathogenesis of topical steroid acne.

Authors:  K H Kaidbey; A M Kligman
Journal:  J Invest Dermatol       Date:  1974-01       Impact factor: 8.551

7.  Glaucoma induced by application of corticosteroids to the periorbital region.

Authors:  N V Nielsen; P N Sørensen
Journal:  Arch Dermatol       Date:  1978-06

Review 8.  Adverse effects of topical glucocorticosteroids.

Authors:  Ulrich R Hengge; Thomas Ruzicka; Robert A Schwartz; Michael J Cork
Journal:  J Am Acad Dermatol       Date:  2006-01       Impact factor: 11.527

9.  Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients.

Authors:  Abir Saraswat; Koushik Lahiri; Manas Chatterjee; Shyamanta Barua; Arijit Coondoo; Asit Mittal; Saumya Panda; Murlidhar Rajagopalan; Rajeev Sharma; Anil Abraham; Shyam B Verma; C R Srinivas
Journal:  Indian J Dermatol Venereol Leprol       Date:  2011 Mar-Apr       Impact factor: 2.545

10.  Corticosteroids induce proliferation but do not influence TNF- or IL-1 beta-induced ICAM-1 expression of human dermal microvascular endothelial cells in vitro.

Authors:  U Hettmannsperger; S Tenorio; C E Orfanos; M Detmar
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more
  5 in total

1.  Use of Topical Steroids in Dermatology: A Questionnaire Based Study.

Authors:  Sonali R Karekar; Padmaja A Marathe; Vetrivel Babu Nagarajan; Uday S Khopkar; Siddhi B Chikhalkar; Priyashree K Desai; Minakshi S Dongre
Journal:  Indian Dermatol Online J       Date:  2020-09-19

2.  Knowledge, attitude and practice regarding topical steroids in dermatology outpatients: A cross-sectional study from a tertiary care hospital in Raipur, Chhattisgarh.

Authors:  Namrata Chhabra; Divya Sachdev; Arvind K Shukla
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 May-Jun       Impact factor: 2.545

3.  Magnitude, characteristics and consequences of topical steroid misuse in rural North India: an observational study among dermatology outpatients.

Authors:  Molly Thomas; Celestine C Wong; Pam Anderson; Nathan Grills
Journal:  BMJ Open       Date:  2020-05-18       Impact factor: 2.692

Review 4.  Trichophyton indotineae-An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India and Worldwide-A Multidimensional Perspective.

Authors:  Silke Uhrlaß; Shyam B Verma; Yvonne Gräser; Ali Rezaei-Matehkolaei; Maryam Hatami; Martin Schaller; Pietro Nenoff
Journal:  J Fungi (Basel)       Date:  2022-07-21

5.  Systemic glucocorticoid prescriptions pattern and factors of inappropriate use in primary care institutions of Southwest China.

Authors:  Xiaobo Luo; Shitao Yu; Zhen Zeng; Xunrong Zhou; Yuxi Liu; Lei Wang; Jiaqi Hu; Yue Chang
Journal:  Front Public Health       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.